Stemgent Sells the Stem Cell Reagent and Services Business Unit – MarketWatch
|
Stemgent Sells the Stem Cell Reagent and Services Business Unit
MarketWatch CAMBRIDGE, Mass., Oct 01, 2014 (BUSINESS WIRE) — Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash transaction for approximately $8.5 million. Stemgent is selling the … |
